Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.
The research, undertaken by a team of 44 researchers at 23 institutions across Europe and Canada, including McGill University, is the largest to link the genetic changes that occur in kidney cancer to patient outcomes.
Tick-borne pathogens, known for causing illnesses such as Lyme disease, are on the rise in Central Canada – presenting new risks in areas where they were never previously detected.
The findings from researchers at McGill University and the University of Ottawa demonstrate the need for more comprehensive testing and tracking to detect the spread and potential risk of tick-borne pathogens to human and wildlife populations throughout Canada.
While previous research early in the pandemic suggested that vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.
"Vitamin D supplementation as a public health measure to improve outcomes is not supported by this study. Most importantly, our results suggest that investment in other therapeutic or preventative avenues should be prioritized for COVID-19 randomized clinical trials," say the authors.
A new study examining the link between peanut and tree-nut anaphylaxis in children and holidays found spikes at Halloween and Easter. The study, led by a team of researchers from the Montreal Children’s Hospital of the McGill University Health Centre (MCH-MUHC), found that most were previously unknown allergies, calling for increased awareness.
